Every year, malaria kills more than 600,000 people worldwide. Most of them are children under 5 in sub-Saharan Africa. But the disease isn’t confined to poor, rural areas – it’s a global threat that ...

A new malaria vaccine showed encouraging results in a phase 1 study conducted in Bamako, Mali, West Africa, a region where malaria remains a year-round threat to public health. Published in NEJM ...

Share on Pinterest An effective new malaria vaccine, Mosquirix, has rolled out in Cameroon and could reduce the risk of all-cause mortality in children by 13%. Image credit: ETIENNE NSOM/Getty Images.

Despite decades of efforts to combat it, malaria remains a major global health threat. According to the World Health ...

Currently licensed and approved malaria subunit vaccines provide modest, short-lived protection against malaria. Immunization with live-attenuated Plasmodium falciparum malaria parasites is an ...

Structural insights into a potent antimalarial drug candidate's interaction with the malaria parasite Plasmodium falciparum have paved the way for drug-resistant malaria therapies, according to a new ...

Malaria parasites in infected patients being treated with atovaquone tend to develop a resistance to the drug. Because of this, atovaquone by itself is not used as a malaria treatment nor has not been ...

Johns Hopkins study supports potential for injectable ‘chemical vaccine’ for malaria using atovaquone Researchers demonstrate in mouse model that key mutation that renders malaria parasites resistant ...

There will be little to celebrate on World Malaria Day on 25 April. Global malaria cases, which stood at 238 million in 2018, ...

Malaria is caused by a eukaryotic microbe of the Plasmodium genus, and is responsible for more deaths than all other parasitic diseases combined. In order to transmit from the human host to the ...